Evidence map›Paper›PMID 12163423›Full record

ArticleCirculation2002

Prognostic value of coronary vascular endothelial dysfunction.

Julian P J Halcox, William H Schenke, Gloria Zalos, Rita Mincemoyer, Abhiram Prasad, Myron A Waclawiw, Khaled R A Nour, Arshed A Quyyumi

5 registry-linked trialsOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Circulation, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 415 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
415citing papers in PubMed, 3 pooled it
65.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04338165 phase2unknown statusstarted 2021, after this paper: background citation

Effect of Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography : a Monocentric, Prospective, Randomized and Open-label Phase II Trial

Ran2021Enrolled66Registered outcomes6Posted comparisons0ConditionsAtherosclerotic Cardiovascular DiseaseArmsEvolocumab 140 MG/ML [Repatha]
Open the trial in the graph
NCT00600106 nacompletednot on this map

WISE Ancillary Study Data Analyses: Efficacy of Hormone Replacement on Myocardial Ischemia in Postmenopausal Women With Normal/Minimal Coronary Artery Disease: Data Analysis

TypeinterventionalSponsorCedars-Sinai Medical CenterRan1999 to 2010Enrolled37ConditionsMyocardial IschemiaArms1/10 NA/EE, Placebo
NCT00738049 phase2completednot on this mapstarted 2009, after this paper: background citation

A Phase 2, Investigator-Initiated, Feasibility Study to Evaluate the Mechanisms of Coronary Endothelial Dysfunction Imaged As Resting Myocardial Perfusion Heterogeneity After Endothelin Receptor Blockade With Darusentan

TypeinterventionalSponsorK.Lance GouldRan2009 to 2011Enrolled40ConditionsCoronary Artery Disease, Endothelial DysfunctionArmsdarusentan 100 mg
NCT02809157 unknown statusnot on this mapstarted 2014, after this paper: background citation

Non-invasive Fractional Flow Reserve CT (FFRCT) Scan for the Study of Coronary Vaso-motion

TypeobservationalSponsorNational Heart Centre SingaporeRan2014 to 2017Enrolled10ConditionsCoronary Artery Disease
NCT04046172 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Treatment of Periodontal Disease in Systemic Lupus Erytematosus: A Pilot Randomized Controlled Clinical Trial

TypeinterventionalSponsorUniversity College, LondonRan2021 to 2023Enrolled200ConditionsSystemic Lupus Erythematosus, PeriodontitisArmssupra/sub gingival root surface debridement, supra-gingival scaling and polishing
3 · Its place in the literature

Who cites it

415 citing papers in PubMed, 3 syntheses or guidelines pooled it, 1,378 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Early-life adversity before age 5 is associated with reduced cardiometabolic health characterized by increased arterial stiffness and inflammation in adolescence.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article

355 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Julian P J HalcoxCardiology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, USA.
William H Schenke
Gloria Zalos
Rita Mincemoyer
Abhiram Prasad
Myron A Waclawiw
Khaled R A Nour
Arshed A Quyyumi
National Heart Lung and Blood Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether patients at increased risk can be identified from a relatively low-risk population by coronary vascular function testing remains unknown. We investigated the relationship between coronary endothelial function and the occurrence of acute unpredictable cardiovascular events (cardiovascular death, myocardial infarction, stroke, and unstable angina) in patients with and without coronary atherosclerosis (CAD). METHODS AND

resultsWe measured the change in coronary vascular resistance (DeltaCVR) and epicardial diameter with intracoronary acetylcholine (ACh, 15 micro g/min) to test endothelium-dependent function and sodium nitroprusside (20 micro g/min) and adenosine (2.2 mg/min) to test endothelium-independent vascular function in 308 patients undergoing cardiac catheterization (132 with and 176 without CAD). Patients underwent clinical follow-up for a mean of 46+/-3 months. Acute vascular events occurred in 35 patients. After multivariate analysis that included CAD and conventional risk factors for atherosclerosis, DeltaCVR with ACh (P=0.02) and epicardial constriction with ACh (P=0.003), together with increasing age, CAD, and body mass index, were independent predictors of adverse events. Thus, patients in the tertile with the best microvascular responses with ACh and those with epicardial dilation with ACh had improved survival by Kaplan-Meier analyses in the total population, as did those in the subset without CAD. Similar improvement in survival was also observed when all adverse events, including revascularization, were considered. Endothelium-independent responses were not predictive of outcome.

conclusionsEpicardial and microvascular coronary endothelial dysfunction independently predict acute cardiovascular events in patients with and without CAD, providing both functional and prognostic information that complements angiographic and risk factor assessment.

Indexed as

Angina, UnstableCoronary Artery DiseaseCoronary CirculationCoronary VesselsDisease-Free SurvivalEndothelium, VascularFemaleFollow-Up StudiesHumansMaleMicrocirculationMiddle AgedMyocardial InfarctionPericardiumPrognosisStrokeVasodilator Agents

Identifiers

PMID12163423
OpenAlexW2019338486

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.